newsfilter
← Latest News
ACCESS Newswire·

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Protagenic Therapeutics, Inc. announced today that warrant exchanges and exercises over the last four trading days have generated